Priority One Nutritional Supplements Inc. – Trademark Portfolio
Entity Type: 03
Priority One Nutritional Supplements Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PRIORITY ONE NUTRITIONAL SUPPLEMENTS. The owner is based in Ferndale, WA.
2681 Delta Ring Rd.
Ferndale, WA 98248
Showing of trademarks Trademarks
Trademark Classifications
Priority One Nutritional Supplements Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Priority One Nutritional Supplements Inc. have?
Priority One Nutritional Supplements Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does Priority One Nutritional Supplements Inc. file in?
Priority One Nutritional Supplements Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Priority One Nutritional Supplements Inc.'s most well-known trademarks?
Priority One Nutritional Supplements Inc.'s registered trademark portfolio includes well-known marks such as PRIORITY ONE NUTRITIONAL SUPPLEMENTS. These are among 1 currently registered trademark in the portfolio.
What is Priority One Nutritional Supplements Inc.'s trademark registration success rate?
Priority One Nutritional Supplements Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.